Literature DB >> 33221866

Nonfasting Lipids for All Patients?

Zareen Farukhi1, Samia Mora1.   

Abstract

Entities:  

Year:  2021        PMID: 33221866      PMCID: PMC8204949          DOI: 10.1093/clinchem/hvaa195

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  17 in total

1.  2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Scott M Grundy; Neil J Stone; Alison L Bailey; Craig Beam; Kim K Birtcher; Roger S Blumenthal; Lynne T Braun; Sarah de Ferranti; Joseph Faiella-Tommasino; Daniel E Forman; Ronald Goldberg; Paul A Heidenreich; Mark A Hlatky; Daniel W Jones; Donald Lloyd-Jones; Nuria Lopez-Pajares; Chiadi E Ndumele; Carl E Orringer; Carmen A Peralta; Joseph J Saseen; Sidney C Smith; Laurence Sperling; Salim S Virani; Joseph Yeboah
Journal:  J Am Coll Cardiol       Date:  2018-11-10       Impact factor: 24.094

2.  How well do laboratories adhere to recommended guidelines for dyslipidaemia management in Europe? The CArdiac MARker Guideline Uptake in Europe (CAMARGUE) study.

Authors:  Hélène A De Wolf; Michel R Langlois; Janne Suvisaari; Kristin M Aakre; Hannsjörg Baum; Paul Collinson; Christopher J Duff; Damien Gruson; Angelika Hammerer-Lercher; Kari Pulkki; Sanja Stankovic; Ana Stavljenic-Rukavina; Päivi Laitinen
Journal:  Clin Chim Acta       Date:  2020-05-23       Impact factor: 3.786

3.  Fasting Versus Nonfasting and Low-Density Lipoprotein Cholesterol Accuracy.

Authors:  Vasanth Sathiyakumar; Jihwan Park; Asieh Golozar; Mariana Lazo; Renato Quispe; Eliseo Guallar; Roger S Blumenthal; Steven R Jones; Seth S Martin
Journal:  Circulation       Date:  2017-10-16       Impact factor: 29.690

Review 4.  2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult.

Authors:  Todd J Anderson; Jean Grégoire; Glen J Pearson; Arden R Barry; Patrick Couture; Martin Dawes; Gordon A Francis; Jacques Genest; Steven Grover; Milan Gupta; Robert A Hegele; David C Lau; Lawrence A Leiter; Eva Lonn; G B John Mancini; Ruth McPherson; Daniel Ngui; Paul Poirier; John L Sievenpiper; James A Stone; George Thanassoulis; Richard Ward
Journal:  Can J Cardiol       Date:  2016-07-25       Impact factor: 5.223

5.  AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.

Authors:  Paul S Jellinger; Yehuda Handelsman; Paul D Rosenblit; Zachary T Bloomgarden; Vivian A Fonseca; Alan J Garber; George Grunberger; Chris K Guerin; David S H Bell; Jeffrey I Mechanick; Rachel Pessah-Pollack; Kathleen Wyne; Donald Smith; Eliot A Brinton; Sergio Fazio; Michael Davidson
Journal:  Endocr Pract       Date:  2017-04       Impact factor: 3.443

6.  Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM.

Authors:  Michel R Langlois; M John Chapman; Christa Cobbaert; Samia Mora; Alan T Remaley; Emilio Ros; Gerald F Watts; Jan Borén; Hannsjörg Baum; Eric Bruckert; Alberico Catapano; Olivier S Descamps; Arnold von Eckardstein; Pia R Kamstrup; Genovefa Kolovou; Florian Kronenberg; Anne Langsted; Kari Pulkki; Nader Rifai; Grazyna Sypniewska; Olov Wiklund; Børge G Nordestgaard
Journal:  Clin Chem       Date:  2018-05-14       Impact factor: 8.327

7.  Comparison of nonfasting and fasting lipoprotein subfractions and size in 15,397 apparently healthy individuals: An analysis from the VITamin D and OmegA-3 TriaL.

Authors:  Zareen M Farukhi; Olga V Demler; Michael P Caulfield; Krishnaji Kulkarni; Jay Wohlgemuth; Michael Cobble; Heike Luttmann-Gibson; Chunying Li; John R Nelson; Nancy R Cook; Julie E Buring; Ronald M Krauss; JoAnn E Manson; Samia Mora
Journal:  J Clin Lipidol       Date:  2020-02-21       Impact factor: 4.766

8.  Fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events.

Authors:  Samia Mora; Nader Rifai; Julie E Buring; Paul M Ridker
Journal:  Circulation       Date:  2008-08-18       Impact factor: 29.690

Review 9.  2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Donna K Arnett; Roger S Blumenthal; Michelle A Albert; Andrew B Buroker; Zachary D Goldberger; Ellen J Hahn; Cheryl Dennison Himmelfarb; Amit Khera; Donald Lloyd-Jones; J William McEvoy; Erin D Michos; Michael D Miedema; Daniel Muñoz; Sidney C Smith; Salim S Virani; Kim A Williams; Joseph Yeboah; Boback Ziaeian
Journal:  Circulation       Date:  2019-03-17       Impact factor: 29.690

10.  2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.

Authors:  François Mach; Colin Baigent; Alberico L Catapano; Konstantinos C Koskinas; Manuela Casula; Lina Badimon; M John Chapman; Guy G De Backer; Victoria Delgado; Brian A Ference; Ian M Graham; Alison Halliday; Ulf Landmesser; Borislava Mihaylova; Terje R Pedersen; Gabriele Riccardi; Dimitrios J Richter; Marc S Sabatine; Marja-Riitta Taskinen; Lale Tokgozoglu; Olov Wiklund
Journal:  Eur Heart J       Date:  2020-01-01       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.